UnitedHealth Group (UNH) Price Target Raised to $260.00

UnitedHealth Group (NYSE:UNH) had its price objective lifted by stock analysts at Deutsche Bank to $260.00 in a note issued to investors on Wednesday. The firm presently has a “buy” rating on the healthcare conglomerate’s stock. Deutsche Bank’s target price would suggest a potential upside of 11.64% from the stock’s previous close.

Other equities research analysts have also issued research reports about the stock. Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $219.00 price objective on the stock in a research note on Thursday, September 21st. Citigroup increased their price objective on shares of UnitedHealth Group from $213.00 to $235.00 and gave the stock a “buy” rating in a research note on Wednesday, October 18th. Leerink Swann reiterated a “buy” rating and set a $240.00 price objective (up previously from $225.00) on shares of UnitedHealth Group in a research note on Wednesday, October 18th. Cantor Fitzgerald reiterated a “buy” rating and set a $208.00 price objective on shares of UnitedHealth Group in a research note on Tuesday, October 17th. Finally, Jefferies Group increased their price objective on shares of UnitedHealth Group from $215.00 to $225.00 and gave the stock a “buy” rating in a research note on Friday, October 13th. Three analysts have rated the stock with a hold rating and twenty-five have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus price target of $238.30.

UnitedHealth Group (UNH) traded up $4.26 on Wednesday, reaching $232.90. 6,852,400 shares of the company traded hands, compared to its average volume of 3,225,820. The firm has a market capitalization of $230,070.00, a price-to-earnings ratio of 21.75, a price-to-earnings-growth ratio of 1.53 and a beta of 0.66. UnitedHealth Group has a 52-week low of $156.09 and a 52-week high of $235.00. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.52.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share for the quarter, topping the consensus estimate of $2.50 by $0.09. The firm had revenue of $52.06 billion for the quarter, compared to analyst estimates of $51.57 billion. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. UnitedHealth Group’s quarterly revenue was up 9.5% on a year-over-year basis. During the same quarter in the prior year, the business earned $2.11 earnings per share. equities analysts anticipate that UnitedHealth Group will post 9.99 EPS for the current year.

In related news, insider Thomas E. Roos sold 975 shares of the firm’s stock in a transaction that occurred on Thursday, October 19th. The shares were sold at an average price of $205.47, for a total transaction of $200,333.25. Following the transaction, the insider now owns 24,630 shares in the company, valued at $5,060,726.10. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Larry C. Renfro sold 22,598 shares of the firm’s stock in a transaction that occurred on Friday, December 15th. The shares were sold at an average price of $221.75, for a total transaction of $5,011,106.50. Following the transaction, the chief executive officer now owns 195,314 shares in the company, valued at approximately $43,310,879.50. The disclosure for this sale can be found here. Insiders have sold 34,630 shares of company stock worth $7,669,416 in the last quarter. Company insiders own 0.89% of the company’s stock.

Several hedge funds and other institutional investors have recently bought and sold shares of UNH. BlackRock Inc. boosted its stake in UnitedHealth Group by 1.2% in the 2nd quarter. BlackRock Inc. now owns 69,430,416 shares of the healthcare conglomerate’s stock worth $12,873,786,000 after purchasing an additional 796,654 shares during the period. Vanguard Group Inc. boosted its stake in UnitedHealth Group by 2.5% in the 2nd quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock worth $11,974,168,000 after purchasing an additional 1,588,516 shares during the period. FMR LLC boosted its stake in UnitedHealth Group by 2.1% in the 2nd quarter. FMR LLC now owns 56,101,668 shares of the healthcare conglomerate’s stock worth $10,402,371,000 after purchasing an additional 1,168,324 shares during the period. State Street Corp boosted its stake in UnitedHealth Group by 2.5% in the 1st quarter. State Street Corp now owns 45,724,509 shares of the healthcare conglomerate’s stock worth $7,499,276,000 after purchasing an additional 1,122,534 shares during the period. Finally, Capital World Investors boosted its stake in UnitedHealth Group by 1.0% in the 3rd quarter. Capital World Investors now owns 41,616,604 shares of the healthcare conglomerate’s stock worth $5,826,325,000 after purchasing an additional 401,303 shares during the period. Institutional investors and hedge funds own 86.09% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “UnitedHealth Group (UNH) Price Target Raised to $260.00” was first posted by American Banking and Market News and is the property of of American Banking and Market News. If you are accessing this piece of content on another site, it was stolen and republished in violation of international copyright and trademark law. The legal version of this piece of content can be accessed at https://www.americanbankingnews.com/2018/01/17/unitedhealth-group-unh-price-target-raised-to-260-00.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)